To explore the activation of the anti-tumor function of immune cells after Ab-like RNA NP treatment, we measured the ratio of degranulating T lymphocytes and natural killer (NK) cells in tumor via CD107a staining. This evidence concerns the gene LAMP1 and neoplasm.